Intensive peri-operative use of factor VIII and the Arg593→Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A

✍ Scribed by C.L. ECKHARDT; L.A. MENKE; C.H. VAN OMMEN; J.H. VAN DER LEE; R.B. GESKUS; P.W. KAMPHUISEN; M. PETERS; K. FIJNVANDRAAT

• Book ID: 109152911
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 143 KB
• Volume: 7
• Category: Article
• ISSN: 1538-7933
• DOI: 10.1111/j.1538-7836.2009.03357.x